Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Tjan-Heijnen, Vivianne C. G."'
Autor:
Slotman E; Technical Medical Centre, Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Netherlands Association for Palliative Care, Utrecht, Netherlands., Weijzen F; Technical Medical Centre, Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands., Fransen HP; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Netherlands Association for Palliative Care, Utrecht, Netherlands., van Hoeve JC; Technical Medical Centre, Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands., Huijben AMT; Department of Internal Medicine, Maasstad Hospital, Rotterdam, Netherlands., Kuip EJM; Department of Medical Oncology and Department of Anesthesiology, Pain and Palliative Care, Radboud Medical Center, Nijmegen, Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Kunst PWA; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Department of Pulmonology, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands., van Laarhoven HWM; Medical Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands.; Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, Netherlands., Tol J; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Research Institute GROW, Maastricht University Medical Centre, Maastricht, Netherlands., Raijmakers NJH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Netherlands Association for Palliative Care, Utrecht, Netherlands., van der Linden YM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Department of Radiotherapy, Leiden University Medical Centre, Leiden, Netherlands.; Centre of Expertise in Palliative Care, Leiden University Medical Centre, Leiden, Netherlands., Siesling S; Technical Medical Centre, Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 May 15; Vol. 154 (10), pp. 1786-1793. Date of Electronic Publication: 2024 Jan 24.
Autor:
van de Geer WS; Dept. of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands; Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands; Dept. of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Mathijssen RHJ; Dept. of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., van Riet J; Dept. of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands; Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands; Dept. of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Steeghs N; Dept. of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands., Labots M; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands., van Herpen C; Dept. of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Devriese LA; Dept. of Medical Oncology, Cancer Center, University Medical Center Utrecht, Utrecht, the Netherlands., Tjan-Heijnen VCG; Dept. of Medical Oncology, GROW, Maastricht University Medical Center, Maastricht, the Netherlands., Voest EE; Dept. of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Center for Personalized Cancer Treatment, Rotterdam, the Netherlands; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands., Sleijfer S; Dept. of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands; Center for Personalized Cancer Treatment, Rotterdam, the Netherlands., Martens JWM; Dept. of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Cuppen E; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, the Netherlands; Hartwig Medical Foundation, Amsterdam, the Netherlands., van de Werken HJG; Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands; Dept. of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands; Dept. of Immunology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands. Electronic address: h.vandewerken@erasmusmc.nl., Bins S; Dept. of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands. Electronic address: s.bins@erasmusmc.nl.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Mar; Vol. 159, pp. 114210. Date of Electronic Publication: 2023 Jan 06.
Autor:
Heesterbeek CJ; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands., Aukema SM; Department of Clinical Genetics, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands., Galjaard RH; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands., Boon EMJ; Department of Human Genetics, and Amsterdam Reproduction & Development Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Srebniak MI; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands., Bouman K; Department of Human Genetics, and Amsterdam Reproduction & Development Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Faas BHW; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands., Govaerts LCP; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands., Hoffer MJV; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands., den Hollander NS; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands., Lichtenbelt KD; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., van Maarle MC; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., van Prooyen Schuurman L; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands.; Department of Human Genetics, and Amsterdam Reproduction & Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Rij MC; Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands., Schuring-Blom GH; Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands., Stevens SJC; Department of Clinical Genetics, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands., Tan-Sindhunata G; Department of Human Genetics, and Amsterdam Reproduction & Development Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Zamani Esteki M; Department of Clinical Genetics, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands.; Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands., de Die-Smulders CEM; Department of Clinical Genetics, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands., Henneman L; Department of Human Genetics, and Amsterdam Reproduction & Development Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Sistermans EA; Department of Human Genetics, and Amsterdam Reproduction & Development Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Macville MVE; Department of Clinical Genetics, GROW School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Aug 01; Vol. 40 (22), pp. 2426-2435. Date of Electronic Publication: 2022 Apr 08.
Autor:
Guman NAM; Department of Vascular Medicine, Amsterdam Cardiovascular Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.; Department of Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands., van Geffen RJ; Department of Vascular Medicine, Amsterdam Cardiovascular Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Mulder FI; Department of Vascular Medicine, Amsterdam Cardiovascular Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.; Department of Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands., van Haaps TF; Department of Vascular Medicine, Amsterdam Cardiovascular Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Hovsepjan V; Department of Vascular Medicine, Amsterdam Cardiovascular Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Labots M; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Cirkel GA; Department of Internal Medicine, Meander Medical Center, Amersfoort, the Netherlands., Y F L de Vos F; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Ten Tije AJ; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., Beerepoot LV; Department of Internal Medicine, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, the Netherlands., van Laarhoven HWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam-Schiedam, the Netherlands., Vulink AJE; Department of Medical Oncology, Reinier de Graaf Hospital, Delft, the Netherlands., Los M; Department of Internal Medicine, St Antonius Hospital, Nieuwegein, the Netherlands., Zwinderman AH; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Center, Amsterdam, the Netherlands., Ferwerda B; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Center, Amsterdam, the Netherlands., Lolkema MPJK; Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Büller HR; Department of Vascular Medicine, Amsterdam Cardiovascular Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands., Kamphuisen PW; Department of Vascular Medicine, Amsterdam Cardiovascular Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.; Department of Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands., van Es N; Department of Vascular Medicine, Amsterdam Cardiovascular Science, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Dec; Vol. 19 (12), pp. 2974-2983. Date of Electronic Publication: 2021 Sep 06.
Autor:
Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Petkovic M; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany., Elizalde S; Department of Mathematics, Dartmouth College, Hanover, NH, USA., Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark.; Bioinformatics Research Centre (BiRC), Aarhus University, Aarhus, Denmark., Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Grönroos E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Dewhurst SM; Laboratory for Cell Biology and Genetics, Rockefeller University, New York, NY, USA., Demeulemeester J; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Department of Human Genetics, University of Leuven, Leuven, Belgium., Dentro SC; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Oxford Big Data Institute, University of Oxford, Oxford, UK.; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK., Horswell S; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK., Au L; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK., Haase K; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Escudero M; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK., Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Bakir MA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Xu H; Stanford Cancer Institute, Stanford, CA, USA., Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Lu WT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Mourikis TP; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK., Dietzen M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK., Spain L; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK., Cresswell GD; Bioinformatics and Computational Biology Laboratory, The Francis Crick Institute, London, UK., Biswas D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK., Lamy P; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark., Nordentoft I; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark., Harbst K; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Lund University Cancer Centre, Lund University, Lund, Sweden., Castro-Giner F; Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Yates LR; Wellcome Trust Sanger Institute, Hinxton, UK.; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Caramia F; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia., Jaulin F; INSERM U1279, Gustave Roussy, Villejuif, France., Vicier C; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France., Tomlinson IPM; Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh, UK., Brastianos PK; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Cho RJ; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA., Bastian BC; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA.; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Dyrskjøt L; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark., Jönsson GB; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Lund University Cancer Centre, Lund University, Lund, Sweden., Savas P; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Loi S; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Campbell PJ; Wellcome Trust Sanger Institute, Hinxton, UK., Andre F; INSERM U981, PRISM Institute, Gustave Roussy, Villejuif, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Medical School, Université Paris Saclay, Kremlin Bicetre, France., Luscombe NM; Bioinformatics and Computational Biology Laboratory, The Francis Crick Institute, London, UK.; UCL Genetics Institute, Department of Genetics, Evolution & Environment, University College London, London, UK.; Okinawa Institute of Science & Technology, Okinawa, Japan., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, School of GROW, Maastricht University Medical Center, Maastricht, The Netherlands., Szallasi Z; Danish Cancer Society Research Center, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; 2nd Department of Pathology, SE-NAP Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary., Turajlic S; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK., Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK., Bakhoum SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Schwarz RF; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany. roland.schwarz@mdc-berlin.de.; German Cancer Consortium (DKTK), partner site Berlin, Berlin, Germany. roland.schwarz@mdc-berlin.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. roland.schwarz@mdc-berlin.de., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK. nicholas.mcgranahan.10@ucl.ac.uk., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Medical Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.
Publikováno v:
Nature [Nature] 2020 Nov; Vol. 587 (7832), pp. 126-132. Date of Electronic Publication: 2020 Sep 02.
Autor:
Priestley P; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Hartwig Medical Foundation Australia, Sydney, New South Wales, Australia., Baber J; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Hartwig Medical Foundation Australia, Sydney, New South Wales, Australia., Lolkema MP; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Steeghs N; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Netherlands Cancer Institute/Antoni van Leeuwenhoekhuis, Amsterdam, The Netherlands., de Bruijn E; Hartwig Medical Foundation, Amsterdam, The Netherlands., Shale C; Hartwig Medical Foundation Australia, Sydney, New South Wales, Australia., Duyvesteyn K; Hartwig Medical Foundation, Amsterdam, The Netherlands., Haidari S; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands., van Hoeck A; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands., Onstenk W; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands., Voda M; Hartwig Medical Foundation, Amsterdam, The Netherlands., Bloemendal HJ; Meander Medisch Centrum, Amersfoort, The Netherlands.; Radboud University Medical Center, Nijmegen, The Netherlands., Tjan-Heijnen VCG; Maastricht University Medical Center, Maastricht, The Netherlands., van Herpen CML; Radboud University Medical Center, Nijmegen, The Netherlands., Labots M; VU Medical Center, Amsterdam, The Netherlands., Witteveen PO; Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., Smit EF; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Netherlands Cancer Institute/Antoni van Leeuwenhoekhuis, Amsterdam, The Netherlands., Sleijfer S; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Voest EE; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Netherlands Cancer Institute/Antoni van Leeuwenhoekhuis, Amsterdam, The Netherlands., Cuppen E; Hartwig Medical Foundation, Amsterdam, The Netherlands. e.cuppen@hartwigmedicalfoundation.nl.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands. e.cuppen@hartwigmedicalfoundation.nl.; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands. e.cuppen@hartwigmedicalfoundation.nl.
Publikováno v:
Nature [Nature] 2019 Nov; Vol. 575 (7781), pp. 210-216. Date of Electronic Publication: 2019 Oct 23.
Autor:
Reumkens K; Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Tummers MHE; Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Gietel-Habets JJG; Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands., van Kuijk SMJ; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands., Aalfs CM; Department of Clinical Genetics, Academic Medical Centre, Amsterdam, The Netherlands., van Asperen CJ; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., Ausems MGEM; Division of Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Collée M; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands., Dommering CJ; Department of Clinical Genetics, VU University Hospital, Amsterdam, The Netherlands., Kets CM; Department of Human Genetics, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands., van der Kolk LE; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands., Oosterwijk JC; Department of Genetics, Groningen University Medical Center, University of Groningen, Groningen, The Netherlands., Tjan-Heijnen VCG; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Department of Medical Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands., van der Weijden T; Department of Family Medicine, Faculty of Health, Medicine and Life Sciences, School CAPHRI, Maastricht University, Maastricht, The Netherlands., de Die-Smulders CEM; Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands., van Osch LADM; Department of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Department of Health Promotion, Faculty of Health, Medicine and Life Sciences, School CAPHRI, Maastricht University, Maastricht, The Netherlands.
Publikováno v:
Journal of genetic counseling [J Genet Couns] 2019 Jun; Vol. 28 (3), pp. 533-542. Date of Electronic Publication: 2018 Dec 21.
Autor:
van Abbema DL; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands; ACHIEVE Centre for Applied Research, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, Netherlands. Electronic address: d.l.van.abbema@hva.nl., van den Akker M; Department of Family Medicine, Maastricht University, Maastricht, The Netherlands; Department of General Practice, KU Leuven, Leuven, Belgium., Janssen-Heijnen ML; Department of Clinical Epidemiology, Viecuri Medical Centre, Venlo, the Netherlands; Department of Epidemiology, Maastricht University Medical Centre, GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands., van den Berkmortel F; Department of Internal Medicine, Zuyderland Medical Center, Heerlen-Geleen, The Netherlands., Hoeben A; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., de Vos-Geelen J; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Buntinx F; Department of Family Medicine, Maastricht University, Maastricht, The Netherlands; Department of General Practice, KU Leuven, Leuven, Belgium., Kleijnen J; Department of Family Medicine, Maastricht University, Maastricht, The Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. Electronic address: vcg.tjan.heijnen@mumc.nl.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2019 Jan; Vol. 10 (1), pp. 31-41. Date of Electronic Publication: 2018 Apr 26.
Autor:
Knapen LM; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, P.O. BOX 5800, 6202 AZ, Maastricht, The Netherlands; CAPHRI-Care And Primary Health Research Institute, Maastricht University Medical Center+, P.O. BOX 616, 6200 MD, Maastricht, The Netherlands., Beer Y; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, P.O. BOX 5800, 6202 AZ, Maastricht, The Netherlands., Brüggemann RJM; Department of Pharmacy, Radboud University Medical Center, P.O. BOX 9101, 6500 HB, Nijmegen, The Netherlands., Stolk LM; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, P.O. BOX 5800, 6202 AZ, Maastricht, The Netherlands; CAPHRI-Care And Primary Health Research Institute, Maastricht University Medical Center+, P.O. BOX 616, 6200 MD, Maastricht, The Netherlands., Vries F; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, P.O. BOX 5800, 6202 AZ, Maastricht, The Netherlands; CAPHRI-Care And Primary Health Research Institute, Maastricht University Medical Center+, P.O. BOX 616, 6200 MD, Maastricht, The Netherlands; Department of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, P.O. BOX 80082, 3508 TB, Utrecht, The Netherlands; MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, SO16 6YD, UK., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Center+, P.O. BOX 5800, 6202 AZ, Maastricht, The Netherlands; GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center+, P.O. BOX 616, 6200 MD, Maastricht, The Netherlands., Erp NPV; Department of Pharmacy, Radboud University Medical Center, P.O. BOX 9101, 6500 HB, Nijmegen, The Netherlands., Croes S; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, P.O. BOX 5800, 6202 AZ, Maastricht, The Netherlands; CAPHRI-Care And Primary Health Research Institute, Maastricht University Medical Center+, P.O. BOX 616, 6200 MD, Maastricht, The Netherlands. Electronic address: s.croes@mumc.nl.
Publikováno v:
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2018 Feb 05; Vol. 149, pp. 106-113. Date of Electronic Publication: 2017 Oct 29.
Autor:
van den Beuken-van Everdingen MH; Center of Expertise for Palliative Care, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands; Department of Anesthesiology and Pain Management, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands. Electronic address: m.vanden.beuken@mumc.nl., Hochstenbach LM; School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands; Department of Health Services Research, Maastricht University (UM), Maastricht, The Netherlands., Joosten EA; Department of Anesthesiology and Pain Management, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands; School of Mental Health and Neuroscience (MHeNs), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands., Tjan-Heijnen VC; School for Oncology and Developmental Biology (GROW), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands; Department of Medical Oncology, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands., Janssen DJ; Center of Expertise for Palliative Care, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands; Department of Research and Education, Center of Expertise for Chronic Organ Failure, CIRO+, Horn, The Netherlands.
Publikováno v:
Journal of pain and symptom management [J Pain Symptom Manage] 2016 Jun; Vol. 51 (6), pp. 1070-1090.e9. Date of Electronic Publication: 2016 Apr 23.